— Protocol
Tirzepatide reconstitution protocol
Step-by-step reconstitution and storage parameters for tirzepatide lyophilized vials. Reference values derived from published handling literature.
— Research reconstitution calculator
Tirzepatide
Reference math for research handling. Not a dosing recommendation.
| Intensity | Dose | Draw | Frequency |
|---|---|---|---|
| maintenance | 2.5 mg | 0.5 mL | Once weekly SC |
| standard | 7.5 mg | 1.5 mL | Once weekly SC |
| aggressive | 15 mg | 3 mL | Once weekly SC |
Intensities summarized from published literature — not a dosing recommendation. For research use only. Not for human or veterinary use.
This protocol describes the reconstitution and storage of lyophilized tirzepatide in standard research workflows. All values are derived from published compound-handling literature and from the parameters used in major clinical research protocols. Selection of any specific concentration or interval is the responsibility of the qualified investigator.
At a glance
| Parameter | Value |
|---|---|
| Recommended diluent | Bacteriostatic Water (USP, 0.9% benzyl alcohol) |
| Recommended volume (10 mg vial) | 2.0 mL |
| Final concentration | 5 mg/mL |
| Stability — lyophilized | ≥24 months at -20 °C, light-protected, sealed |
| Stability — reconstituted | 30 days at 2–8 °C in original vial |
| Freeze-thaw | Avoid on reconstituted solution. Aliquot if longer-term storage needed. |
Procedure
- Equilibrate. Allow the sealed vial to come to room temperature before reconstitution. Cold glass + cold diluent can produce condensation on the stopper.
- Sterile prep. Wipe the stopper with isopropyl alcohol and allow to dry. Use a sterile syringe and a 21G or larger needle for transfer.
- Inject diluent slowly. Direct the stream of bacteriostatic water along the inner glass wall — not directly onto the lyophilized cake. Rapid injection onto the cake can foam the compound and damage structure.
- Dissolve gently. Swirl the vial in a slow rotational motion. Do not shake. The lyophilized cake should dissolve within 30–60 seconds.
- Verify. Solution should be clear and colorless. If cloudy, particulate, or discolored, do not use — contact Merit (info@meritpeptides.com) with the lot number.
Storage
Reconstituted tirzepatide is stable for approximately 30 days at 2–8 °C when kept in the original vial. The benzyl alcohol in bacteriostatic water acts as a preservative against microbial growth during this period. Light-protect the vial (most vial stoppers are partially light-permeable).
For storage longer than 30 days, aliquot into sterile single-use tubes and freeze at -20 °C or colder. Avoid freeze-thaw cycles — each cycle introduces degradation. Lyophilized (pre-reconstitution) stability is significantly longer: at least 24 months at -20 °C light-protected.
What you'll need
- Sterile bacteriostatic water (USP) — typically 30 mL multi-dose vial
- Sterile syringes (1 mL or 3 mL) with appropriate-gauge needles
- Isopropyl alcohol wipes (70%)
- Sharps disposal container
- Sterile aliquot tubes if extended freezer storage is planned
Notes
This protocol describes reconstitution parameters used in published compound-handling literature. It is not a recommendation for any particular study design or application. Selection of concentration, interval, and route is the responsibility of the qualified investigator under appropriate institutional oversight. For research use only. Not for human or veterinary use.
References
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM 2022;387:205–216. PMID: 35658024
- Coskun T, Sloop KW, Loghin C, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus. Mol Metab 2018;18:3–14. PMID: 30473097
For research use only. Not for human or veterinary use. Not FDA-approved. Reference information summarized from published literature — not medical or dosing advice.
— More reconstitution protocols
BPC-157 + TB-500 blend reconstitution protocol
Reconstitution of the BPC-157 + TB-500 blended vial. Why the two peptides are co-formulated and what each contributes mechanistically to tissue-repair research.
BPC-157 reconstitution protocol
Reconstitution and storage for BPC-157 (Body Protection Compound). Particular notes on stability of the peptide at varying pH and the role of acetate counterion.
CJC-1295 / Ipamorelin reconstitution protocol
Reconstitution for blended CJC-1295 + Ipamorelin vials. Why the combination is shipped together, single-vial handling, and references for the underlying GHRH/GHRP pharmacology.
Epitalon reconstitution protocol
Reconstitution for epitalon (Ala-Glu-Asp-Gly), the synthetic pineal-derived tetrapeptide studied in aging research.